Evidence map›Paper›PMID 25830043›Full record

ArticleJournal of gastrointestinal oncology2015

Exploring signet-ring cells in pregnant female.

Anil Kumar Dhull, Pooja Gogia, Rajeev Atri, Rakesh Dhankhar, Vivek Kaushal, Sunita Singh, Rajeev Sen, Manoj Pal, Amit Lathwal

Open access · greenAbstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Anil Kumar Dhull1 Department of Radiation Oncology, 2 Department of Pathology, Post Graduate Institute of Medical Sciences, Rohtak, India ; 3 Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India ; 4 Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Pooja Gogia1 Department of Radiation Oncology, 2 Department of Pathology, Post Graduate Institute of Medical Sciences, Rohtak, India ; 3 Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India ; 4 Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Rajeev Atri1 Department of Radiation Oncology, 2 Department of Pathology, Post Graduate Institute of Medical Sciences, Rohtak, India ; 3 Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India ; 4 Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Rakesh Dhankhar1 Department of Radiation Oncology, 2 Department of Pathology, Post Graduate Institute of Medical Sciences, Rohtak, India ; 3 Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India ; 4 Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Vivek Kaushal1 Department of Radiation Oncology, 2 Department of Pathology, Post Graduate Institute of Medical Sciences, Rohtak, India ; 3 Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India ; 4 Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Sunita Singh1 Department of Radiation Oncology, 2 Department of Pathology, Post Graduate Institute of Medical Sciences, Rohtak, India ; 3 Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India ; 4 Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Rajeev Sen1 Department of Radiation Oncology, 2 Department of Pathology, Post Graduate Institute of Medical Sciences, Rohtak, India ; 3 Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India ; 4 Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Manoj Pal1 Department of Radiation Oncology, 2 Department of Pathology, Post Graduate Institute of Medical Sciences, Rohtak, India ; 3 Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India ; 4 Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Amit Lathwal1 Department of Radiation Oncology, 2 Department of Pathology, Post Graduate Institute of Medical Sciences, Rohtak, India ; 3 Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India ; 4 Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Rajiv Gandhi Cancer Institute and Research Centre · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrimary signet-ring cell carcinoma (SRCC) of the colon and rectum are rare form, which present at an advanced stage and have poor prognosis. Different treatment policies of SRCC during different gestational age of pregnancy are explored from the literature. CASE STUDY: A 26-year-old young pregnant female with 10-week gestation presented with constipation and blood in stools and on per rectal examination a tender circumferential stricture was present 2 cm above the anal verge. Magnetic resonant imaging (MRI) pelvis of the patient revealed rectal thickening, the biopsy of which revealed characteristic appearance of "linitis plastica" and diagnosed as poorly differentiated adenocarcinoma with signet ring morphology with wide spread positivity for cytokeratin & p53. With this diagnosis, patient underwent medical termination of pregnancy (MTP). DISCUSSION: SRCC of the colon comprises about only 1% of all cases of colon cancer. When compared with other types of adenocarcinoma, patients with SRCC in the colon are younger and more likely to experience lymph node metastasis. Its incidence in pregnancy is estimated to be less than 0.1%. Certainly, any pregnant patient who reports rectal bleeding or has hemoccult positive stool on examination deserves careful evaluation to rule out cancer. The complex treatment of colorectal cancer in pregnancy is based on the gestational age of the fetus, tumor stage and need for emergent vs. elective management.

Indexed as

colorectal cancerpregnancySignet-ring cell carcinoma (SRCC)signet-ring cells

Identifiers

PMID25830043
PMCPMC4311090
OpenAlexW2139790316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.